-
1
-
-
0025938038
-
Identification and characterization of the familial adenomatous polyposis coli gene
-
Groden J, Thliveris A, Samowitz W, et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
-
(1991)
Cell
, vol.66
, pp. 589-600
-
-
Groden, J.1
Thliveris, A.2
Samowitz, W.3
-
2
-
-
0025817880
-
Identification of FAP locus genes from chromosome 5q21
-
Kinzler KW, Nilbert MC, Su LK, et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253(5020):661-665
-
(1991)
Science
, vol.253
, Issue.5020
, pp. 661-665
-
-
Kinzler, K.W.1
Nilbert, M.C.2
Su, L.K.3
-
3
-
-
0035432406
-
Fibromatoses in childhood: The desmoid/fibromatosis complex
-
Dormans JP, Spiegel D, Meyer J, et al (2001) Fibromatoses in childhood: the desmoid/fibromatosis complex. Med Pediatr Oncol 37:126-131
-
(2001)
Med Pediatr Oncol
, vol.37
, pp. 126-131
-
-
Dormans, J.P.1
Spiegel, D.2
Meyer, J.3
-
4
-
-
0031004283
-
Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder
-
Alman BA, Pajerski ME, Diaz-Cano S, et al (1997) Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diag Mol Pathol 6(2):98-101
-
(1997)
Diag Mol Pathol
, vol.6
, Issue.2
, pp. 98-101
-
-
Alman, B.A.1
Pajerski, M.E.2
Diaz-Cano, S.3
-
5
-
-
0029849048
-
Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation
-
Scott RJ, Froggatt NJ, Trembath RC, et al (1996) Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet 5(12):1921-1924
-
(1996)
Hum Mol Genet
, vol.5
, Issue.12
, pp. 1921-1924
-
-
Scott, R.J.1
Froggatt, N.J.2
Trembath, R.C.3
-
6
-
-
0030747976
-
Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)
-
Alman BA, Li C, Pajerski ME (1997) Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151(2):329-334
-
(1997)
Am J Pathol
, vol.151
, Issue.2
, pp. 329-334
-
-
Alman, B.A.1
Li, C.2
Pajerski, M.E.3
-
7
-
-
0035816273
-
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)
-
Tejpar S, Li C, Yu C, et al (2001) Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Br J Cancer 85:98-101
-
(2001)
Br J Cancer
, vol.85
, pp. 98-101
-
-
Tejpar, S.1
Li, C.2
Yu, C.3
-
8
-
-
0033547361
-
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
-
Tejpar S, Nollet F, Li C, et al (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18(47):6615-6620
-
(1999)
Oncogene
, vol.18
, Issue.47
, pp. 6615-6620
-
-
Tejpar, S.1
Nollet, F.2
Li, C.3
-
9
-
-
0033590172
-
Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways
-
Miller JR, Hocking AM, Brown JD, et al (1999) Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18:7860-7872
-
(1999)
Oncogene
, vol.18
, pp. 7860-7872
-
-
Miller, J.R.1
Hocking, A.M.2
Brown, J.D.3
-
10
-
-
0032830931
-
TCF transcription factors: Molecular switches in carcinogenesis
-
Roose J, Clevers H (1999) TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta 1424:M23-M37
-
(1999)
Biochim Biophys Acta
, vol.1424
-
-
Roose, J.1
Clevers, H.2
-
11
-
-
0037076354
-
beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds
-
Cheon SS, Cheah AY, Turley S, et al (2002) beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci U S A 99(10):6973-6978
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.10
, pp. 6973-6978
-
-
Cheon, S.S.1
Cheah, A.Y.2
Turley, S.3
-
12
-
-
0035917003
-
Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis
-
Bertario L, Russo A, Sala P, et al (2001) Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95(2):102-107
-
(2001)
Int J Cancer
, vol.95
, Issue.2
, pp. 102-107
-
-
Bertario, L.1
Russo, A.2
Sala, P.3
-
13
-
-
0037797281
-
Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis
-
Bertario L, Russo A, Sala P, et al (2003) Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21(9):1698-1707
-
(2003)
J Clin Oncol
, vol.21
, Issue.9
, pp. 1698-1707
-
-
Bertario, L.1
Russo, A.2
Sala, P.3
-
14
-
-
0028000073
-
Phenotypic expression in familial adenomatous polyposis: Partial prediction by mutation analysis
-
Nugent KP, Phillips RK, Hodgson SV, et al (1994) Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut 35(11):1622-1623
-
(1994)
Gut
, vol.35
, Issue.11
, pp. 1622-1623
-
-
Nugent, K.P.1
Phillips, R.K.2
Hodgson, S.V.3
-
15
-
-
0028883366
-
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene
-
Davies DR, Armstrong JG, Thakker N, et al (1995) Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 57(5):1151-1158
-
(1995)
Am J Hum Genet
, vol.57
, Issue.5
, pp. 1151-1158
-
-
Davies, D.R.1
Armstrong, J.G.2
Thakker, N.3
-
16
-
-
0033513022
-
Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli
-
Gebert JF, Dupon C, Kadmon M, et al (1999) Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli. Ann Surg 229(3):350-361
-
(1999)
Ann Surg
, vol.229
, Issue.3
, pp. 350-361
-
-
Gebert, J.F.1
Dupon, C.2
Kadmon, M.3
-
17
-
-
0028905406
-
Familial adenomatous polyposis: Desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444
-
Caspari R, Olschwang S, Friedl W, et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4(3):337-340
-
(1995)
Hum Mol Genet
, vol.4
, Issue.3
, pp. 337-340
-
-
Caspari, R.1
Olschwang, S.2
Friedl, W.3
-
18
-
-
19244364521
-
Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene
-
Eccles DM, van der Luijt R, Breukel C, et al (1996) Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 59(6):1193-1201
-
(1996)
Am J Hum Genet
, vol.59
, Issue.6
, pp. 1193-1201
-
-
Eccles, D.M.1
van der Luijt, R.2
Breukel, C.3
-
19
-
-
0030963907
-
The clinical correlates of a 3′ truncating mutation (codons 1982-1983) in the adenomatous polyposis coli gene
-
Gardner RJ, Kool D, Edkins E, et al (1997) The clinical correlates of a 3′ truncating mutation (codons 1982-1983) in the adenomatous polyposis coli gene. Gastroenterology 113(1):326-331
-
(1997)
Gastroenterology
, vol.113
, Issue.1
, pp. 326-331
-
-
Gardner, R.J.1
Kool, D.2
Edkins, E.3
-
20
-
-
0034075935
-
A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor
-
Couture J, Mitri A, Lagace R, et al (2000) A germline mutation at the extreme 3′ end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 57(3):205-212
-
(2000)
Clin Genet
, vol.57
, Issue.3
, pp. 205-212
-
-
Couture, J.1
Mitri, A.2
Lagace, R.3
-
21
-
-
0029446166
-
Genotype-phenotype correlations at the adenomatous polyposis coli (APC) gene
-
Fodde R, Khan P (1995) Genotype-phenotype correlations at the adenomatous polyposis coli (APC) gene. Crit Rev Oncog 6:291-303
-
(1995)
Crit Rev Oncog
, vol.6
, pp. 291-303
-
-
Fodde, R.1
Khan, P.2
-
22
-
-
0035173781
-
Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes
-
Houlston R, Crabtree M, Phillips R, et al (2001) Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut 48(1):1-5
-
(2001)
Gut
, vol.48
, Issue.1
, pp. 1-5
-
-
Houlston, R.1
Crabtree, M.2
Phillips, R.3
-
23
-
-
14944384306
-
Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor)
-
Li CF, Kandel C, Baliko F, et al (2005) Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor). Oncogene 24(9):1615-1624
-
(2005)
Oncogene
, vol.24
, Issue.9
, pp. 1615-1624
-
-
Li, C.F.1
Kandel, C.2
Baliko, F.3
-
24
-
-
0030877824
-
Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodelling
-
Preissner KT, May AE, Wohn KD, et al (1997) Molecular crosstalk between adhesion receptors and proteolytic cascades in vascular remodelling. Thromb Haemost 78(1):88-95
-
(1997)
Thromb Haemost
, vol.78
, Issue.1
, pp. 88-95
-
-
Preissner, K.T.1
May, A.E.2
Wohn, K.D.3
-
25
-
-
0030926412
-
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
-
Nykjaer A, Conese M, Christensen EI, et al (1997) Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J 16(10):2610-2620
-
(1997)
EMBO J
, vol.16
, Issue.10
, pp. 2610-2620
-
-
Nykjaer, A.1
Conese, M.2
Christensen, E.I.3
-
26
-
-
0034014726
-
Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis
-
Kwaan HC, Wang J, Svoboda K, et al (2000) Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. Br J Cancer 82(10):1702-1708
-
(2000)
Br J Cancer
, vol.82
, Issue.10
, pp. 1702-1708
-
-
Kwaan, H.C.1
Wang, J.2
Svoboda, K.3
-
27
-
-
0031902286
-
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
-
Bajou K, Noel A, Gerard RD, et al (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4(8):923-928
-
(1998)
Nat Med
, vol.4
, Issue.8
, pp. 923-928
-
-
Bajou, K.1
Noel, A.2
Gerard, R.D.3
-
28
-
-
0037362557
-
Role of plasminogen activator-plasmin system in tumor angiogenesis
-
Rakic JM, Maillard C, Jost M, et al (2003) Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci 60(3):463-473
-
(2003)
Cell Mol Life Sci
, vol.60
, Issue.3
, pp. 463-473
-
-
Rakic, J.M.1
Maillard, C.2
Jost, M.3
-
29
-
-
0026704193
-
Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response
-
Descheemaeker KA, Wyns S, Nelles L, et al (1992) Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J Biol Chem 267:15086-15091
-
(1992)
J Biol Chem
, vol.267
, pp. 15086-15091
-
-
Descheemaeker, K.A.1
Wyns, S.2
Nelles, L.3
-
30
-
-
0029144441
-
Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53
-
Kunz C, Pebler S, Otte J, et al (1995) Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 23:3710-3717
-
(1995)
Nucleic Acids Res
, vol.23
, pp. 3710-3717
-
-
Kunz, C.1
Pebler, S.2
Otte, J.3
-
31
-
-
0032101178
-
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
-
Dennler S, Itoh S, Vivien D, et al (1998) Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17(11):3091-3100
-
(1998)
EMBO J
, vol.17
, Issue.11
, pp. 3091-3100
-
-
Dennler, S.1
Itoh, S.2
Vivien, D.3
-
32
-
-
0028901713
-
Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction
-
Eriksson P, Kallin B, van 't Hooft FM, et al (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92(6):1851-1855
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, Issue.6
, pp. 1851-1855
-
-
Eriksson, P.1
Kallin, B.2
van 't Hooft, F.M.3
-
33
-
-
16944367480
-
Five frequent polymorphrism of the PAI-1 gene. Lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population
-
Henry M, Chomiki N, Scarabin PY, et al (1997) Five frequent polymorphrism of the PAI-1 gene. Lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol 17:851-858
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 851-858
-
-
Henry, M.1
Chomiki, N.2
Scarabin, P.Y.3
-
34
-
-
3242720491
-
The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels
-
Diamanti-Kandarakis E, Palioniko G, Alexandraki K, et al (2004) The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol 150(6):793-798
-
(2004)
Eur J Endocrinol
, vol.150
, Issue.6
, pp. 793-798
-
-
Diamanti-Kandarakis, E.1
Palioniko, G.2
Alexandraki, K.3
-
35
-
-
0033785047
-
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
-
Tassies D, Espinosa G, Munoz-Rodriguez FJ, et al (2000) The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum 43(10):2349-2358
-
(2000)
Arthritis Rheum
, vol.43
, Issue.10
, pp. 2349-2358
-
-
Tassies, D.1
Espinosa, G.2
Munoz-Rodriguez, F.J.3
-
36
-
-
0035820317
-
Plasminogen-activator- inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients
-
Menges T, Hermans PW, Little SG, et al (2001) Plasminogen-activator- inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet 357(9262):1096-1097
-
(2001)
Lancet
, vol.357
, Issue.9262
, pp. 1096-1097
-
-
Menges, T.1
Hermans, P.W.2
Little, S.G.3
-
37
-
-
0036281559
-
PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells
-
Alvarez-Millan JJ, Bocos C, Ferrin V, et al (2002) PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells. Oncology 62(3):286-290
-
(2002)
Oncology
, vol.62
, Issue.3
, pp. 286-290
-
-
Alvarez-Millan, J.J.1
Bocos, C.2
Ferrin, V.3
-
38
-
-
0037469081
-
Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis
-
Loktionov A, Watson MA, Stebbings WS, et al (2003) Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis. Cancer Lett 189(2):189-196
-
(2003)
Cancer Lett
, vol.189
, Issue.2
, pp. 189-196
-
-
Loktionov, A.1
Watson, M.A.2
Stebbings, W.S.3
-
39
-
-
0142259261
-
Prevalence of PAI-1 gene 4G/5G genotype in Azerbaijan and Kyrgyzstan populations: Literature review
-
Balta G, Altay C, Gurgey A (2003) Prevalence of PAI-1 gene 4G/5G genotype in Azerbaijan and Kyrgyzstan populations: literature review. J Thromb Haemost 1(4):858-859
-
(2003)
J Thromb Haemost
, vol.1
, Issue.4
, pp. 858-859
-
-
Balta, G.1
Altay, C.2
Gurgey, A.3
-
40
-
-
0037138428
-
Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas
-
Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G, Brunet JS, Foulkes WD, Narod SA (2002). Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 97(6):807-810
-
(2002)
Int J Cancer
, vol.97
, Issue.6
, pp. 807-810
-
-
Ghadirian, P.1
Liu, G.2
Gallinger, S.3
Schmocker, B.4
Paradis, A.J.5
Lal, G.6
Brunet, J.S.7
Foulkes, W.D.8
Narod, S.A.9
-
41
-
-
0031781181
-
Genotype-phenotype correlations in attenuated adenomatous polyposis coli
-
Soravia C, Berk T, Madlensky L, et al (1998) Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 62:1290-1301
-
(1998)
Am J Hum Genet
, vol.62
, pp. 1290-1301
-
-
Soravia, C.1
Berk, T.2
Madlensky, L.3
-
42
-
-
0031092820
-
An alternative method for PAI-1 promoter polymorphism (4G/5G) typing
-
Margaglione M, Grandone E, Cappucci G, et al (1997) An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 77(3):605-606
-
(1997)
Thromb Haemost
, vol.77
, Issue.3
, pp. 605-606
-
-
Margaglione, M.1
Grandone, E.2
Cappucci, G.3
-
44
-
-
0032168986
-
The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules
-
Berrueta L, Kraeft SK, Tirnauer JS, et al (1998) The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules. Proc Natl Acad Sci U S A 95(18):10596-10601
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, Issue.18
, pp. 10596-10601
-
-
Berrueta, L.1
Kraeft, S.K.2
Tirnauer, J.S.3
-
45
-
-
0032585647
-
EB1, a protein which interacts with the APC tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle
-
Morrison EE, Wardleworth BN, Askham JM, et al (1998) EB1, a protein which interacts with the APC tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle. Oncogene 17(26):3471-3477
-
(1998)
Oncogene
, vol.17
, Issue.26
, pp. 3471-3477
-
-
Morrison, E.E.1
Wardleworth, B.N.2
Askham, J.M.3
-
46
-
-
0032915931
-
EB/RP gene family encodes tubulin binding proteins
-
Juwana JP, Henderikx P, Mischo A, et al (1999) EB/RP gene family encodes tubulin binding proteins. Int J Cancer 81(2):275-284
-
(1999)
Int J Cancer
, vol.81
, Issue.2
, pp. 275-284
-
-
Juwana, J.P.1
Henderikx, P.2
Mischo, A.3
-
47
-
-
0028801360
-
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase
-
Baeg GH, Matsumine A, Kuroda T, et al (1995) The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J 14(22):5618-5625
-
(1995)
EMBO J
, vol.14
, Issue.22
, pp. 5618-5625
-
-
Baeg, G.H.1
Matsumine, A.2
Kuroda, T.3
-
48
-
-
0034688150
-
The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase
-
Ishidate T, Matsumine A, Toyoshima K, et al (2000) The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene 19(3):365-372
-
(2000)
Oncogene
, vol.19
, Issue.3
, pp. 365-372
-
-
Ishidate, T.1
Matsumine, A.2
Toyoshima, K.3
-
49
-
-
9344261842
-
Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation
-
Sturt NJ, Gallagher MC, Bassett P, et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53(12):1832-1836
-
(2004)
Gut
, vol.53
, Issue.12
, pp. 1832-1836
-
-
Sturt, N.J.1
Gallagher, M.C.2
Bassett, P.3
-
50
-
-
0027363063
-
Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse
-
Dietrich WF, Lander ES, Smith JS, et al (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75(4):631-639
-
(1993)
Cell
, vol.75
, Issue.4
, pp. 631-639
-
-
Dietrich, W.F.1
Lander, E.S.2
Smith, J.S.3
-
51
-
-
0034724315
-
Tumorigenesis in the multiple intestinal neoplasia mouse: Redundancy of negative regulators and specificity of modifiers
-
Halberg RB, Katzung DS, Hoff PD, et al (2000) Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc Natl Acad Sci U S A 97(7):3461-3466
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, Issue.7
, pp. 3461-3466
-
-
Halberg, R.B.1
Katzung, D.S.2
Hoff, P.D.3
|